Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
SummaryA head-to-head study published in the New England Journal of Medicine found that Eli Lilly’s obesity drug, Zepbound, resulted in ...
Thursday, June 19, 2025
Tag: Zepbound
Lilly shares on track for worst day since 2021 after downbeat Zepbound sales forecast
Reuters was ahead of competitors with news that Eli Lilly's unscheduled trading update revealed lower-than-expected fourth-quarter sales of the weight-loss ...
News Summarized. Time Saved. Bite-sized news briefs for busy people. No fluff, just facts.